Skip to main content

Table 11 Top 10 HF-specific medications prescribed in the definite HF population

From: The epidemiology of heart failure in the general Australian community - study of heart failure in the Australian primary carE setting (SHAPE): methods

 

HF-specific medications recorded in the notes

Number

Percent

All patients

 1

Bisoprolol

4175

24.7%

 2

Carvedilol

1093

6.5%

 3

Nebivolol

793

4.7%

 4

Metoprolol succinate

646

3.8%

 5

Ivabradine

171

1.0%

 6

Bisoprolol & Sacubitril

113

0.7%

 7

Bisoprolol & Carvedilol

110

0.6%

 8

Eplerenone & Bisoprolol

110

0.6%

 9

Eplerenone

77

0.5%

 10

Bisoprolol & Nebivolol

59

0.3%

Active patients

 1

Bisoprolol

3783

24.5%

 2

Carvedilol

957

6.2%

 3

Nebivolol

736

4.8%

 4

Metoprolol succinate

554

3.6%

 5

Ivabradine

153

1.0%

 6

Bisoprolol & Sacubitril

111

0.7%

 7

Bisoprolol & Carvedilol

107

0.7%

 8

Eplerenone & Bisoprolol

101

0.7%

 9

Eplerenone

72

0.5%

 10

Bisoprolol & Nebivolol

56

0.4%